AUSTIN SPARKMAN: Open Payments
NPI 1760050819 · IRVINE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 17 payments from 6 companies in 2025. Trend: 2023 $150 · 2024 $236 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $165 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: CAPLYTA, Auvelity, XIFAXAN, BREZTRI, VRAYLAR.
Industry payments across KY — which companies pay providers there.
